IntelGenx Corp.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease (NCT03402503) | IntelGenx Corp. | 2018-11-26 |
Track IntelGenx Corp. automatically
Every clearance here is in the API, with alerts when new ones post.